An study of Sage-324 in participants with essential tremor (H-52947)
Description
Content
An open-label study of the long-term safety and tolerability of Sage-324 in participants with essential tremor
The purpose of this study is to determine the long-term safety and tolerability of SAGE324 for the treatment of essential tremor. SAGE-324 is an experimental drug, which means that the FDA has not approved it for the treatment of essential tremor or any other indication.
Contact
Phone 1: 713–798–5989
IRB: H-52947
Status:
Active
Created:
